Ceren Alis

Dr. Ceren Alis

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DADeniz Alis
Deniz Alis
CACeren Alis
Ceren Alis
MYMert Yergin
Mert Yergin
CTCagdas Topel
Cagdas Topel
OAOzan Asmakutlu
Ozan Asmakutlu
EKErcan Karaarslan
Ercan Karaarslan
To investigate the performance of a joint convolutional neural networks-recurrent neural networks (CNN-RNN) using an attention mechanism in identifying and classifying intracranial hemorrhage (ICH) on a large multi-center dataset; to test its performance in a prospective independent sample consisting of consecutive real-world patients. All consecutive patients who underwent emergency non-contrast-enhanced head CT in five different centers were retrospectively gathered. Five neuroradiologists created the ground-truth labels. The development dataset was divided into the training and validation set. After the development phase, we integrated the deep learning model into an independent center’s PACS environment for over six months for assessing the performance in a real clinical setting. Three radiologists created the ground-truth labels of the testing set with a majority voting. A total of 55,179 head CT scans of 48,070 patients, 28,253 men (58.77%), with a mean age of 53.84 ± 17.64 years (range 18–89) were enrolled in the study. The validation sample comprised 5211 head CT scans, with 991 being annotated as ICH-positive. The model's binary accuracy, sensitivity, and specificity on the validation set were 99.41%, 99.70%, and 98.91, respectively. During the prospective implementation, the model yielded an accuracy of 96.02% on 452 head CT scans with an average prediction time of 45 ± 8 s. The joint CNN-RNN model with an attention mechanism yielded excellent diagnostic accuracy in assessing ICH and its subtypes on a large-scale sample. The model was seamlessly integrated into the radiology workflow. Though slightly decreased performance, it provided decisions on the sample of consecutive real-world patients within a minute.

17 July 2025 in Sleep Medicine
Verified
Journal Article
Closed access
CACeren Alis
Ceren Alis
NKNuray Kose
Nuray Kose
SKSibel Sen Kilic
Sibel Sen Kilic
GGGencer Genc
Gencer Genc
SBSerpil Bulut
Serpil Bulut

12 March 2019 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
DADeniz Can Aliş
Deniz Can Aliş
CACeren Alis
Ceren Alis
MTMelih Tutuncu
Melih Tutuncu
NKNaci Kocer
Naci Kocer
CICivan Islak
Civan Islak
OKOsman Kizilkilic
Osman Kizilkilic

8 May 2022 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
CACeren Alis
Ceren Alis
DEDogukan Hazar Emre
Dogukan Hazar Emre
FSFeray Karaali Savrun
Feray Karaali Savrun
AGAyşegül Gündüz
Ayşegül Gündüz
NANurten Uzun Adatepe
Nurten Uzun Adatepe

1 January 2025 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
CACeren Alis
Ceren Alis
DDDerya Selcuk Demirelli
Derya Selcuk Demirelli
EAElvin Ay
Elvin Ay
GGGencer Genc
Gencer Genc
Ceren Alis, Derya Selcuk Demirelli, Elvin Ay, and Gencer Genc. Korean J Pain 2025;38:43-50. https://doi.org/10.3344/kjp.24245

14 September 2022 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
CACeren Alis
Ceren Alis
DADeniz Can Aliş
Deniz Can Aliş
LULebriz Uslu-Besli
Lebriz Uslu-Besli
EKErcan Karaarslan
Ercan Karaarslan
KSKerim Sonmezoglu
Kerim Sonmezoglu
SYSeher Naz Yeni
Seher Naz Yeni
Objectives To describe F-18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (F-18-FDG PET/MRI) along with semiology and electroencephalography (EEG) in patients with gray matter heterotopia (GMH); to evaluate the concordance between F-18-FDG PET/MRI and clinical epileptogenic zone (EZ). Materials & Methods GMH (subcortical heterotopia [SCH] and periventricular nodular heterotopia [PNH]) patients with epilepsy who underwent F-18-FDG PET/MRI were retrospectively enrolled. Two radiologists evaluated brain MRI, while two nuclear medicine specialists assessed the F-18-FDG PET. The SUVmax values of visually hypometabolic cortical areas were compared to the contralateral cortex using a SUVmax threshold value of 10%; the SUVmax values of GMH lesions were compared with that of the right precentral gyrus. The cortex or GMH with hypometabolism on F-18-FDG PET/MRI was considered representative of the EZ. The clinical EZ was identified using EEG and semiology. Results Thirty patients (19 PNH; 11 SCH) with a mean age of 28.46 +/- 9.52 years were enrolled. The heterotopic nodules were ametabolic in 3 patients (10%), hypometabolic in 16 (33.33%), isometabolic in 13 (26.66%), and hypermetabolic in 4 (10%). F-18-FDG PET/MRI demonstrated hypometabolism in the cortex and GMH in 22/30 (73.33%) and 16/30 (53.33%). We could identify a clinical EZ in 18 patients, and 15 out of 18 (83.33%) had concordant F-18-FDG PET/MRI findings. Conclusion Heterotopic nodules in GMH patients show different metabolic patterns on F-18-FDG PET/MRI, with nearly three-quarters of the patients having cortical hypometabolism. F-18-FDG PET/ MRI findings are mostly concordant with the clinical EZ.